ArticleJournal of experimental & clinical cancer research : CR2020

SH3BGRL confers innate drug resistance in breast cancer by stabilizing HER2 activation on cell membrane.

Hui Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.